| Avidity Biosciences Inc (RNA) | |||
|---|---|---|---|
| 19.54 0.55 (2.9%) | 08-08 16:00 | ||
| Open: | 19.74 | Pre. Close: | 18.99 |
| High: | 20.25 | Low: | 18.94 |
| Volume: | 243,372 | Market Cap: | 972M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 20.262 - 20.322 | 20.322 - 20.389 |
| Low: | 18.765 - 18.835 | 18.835 - 18.914 |
| Close: | 19.414 - 19.522 | 19.522 - 19.643 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 23.65  One year: 27.63 |
| Support: | Support1: 17.17 Support2: 15.26 |
| Resistance: | Resistance1: 20.25 Resistance2: 23.65 |
| Pivot: | 17.42 |
| Moving Averages: | MA(5): 18.18 MA(20): 17.42 MA(100): 15.77 MA(250): 18.89 |
| MACD: | MACD(12,26): 0.70 Signal(12,26,9): 0.56 |
| %K %D: | %K(14,3): 84.42 %D(3): 70.63 |
| RSI: | RSI(14): 65.51 |
| 52-Week: | High: 29.25 Low: 10.89 Change(%): 7.6 |
| Average Vol(K): | 3-Month: 377 10-Days: 291 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ RNA ] has closed below upper band by 1.2%. Bollinger Bands are 2.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | |
| Shares Float (M) | 49.76 |
| % Held by Insiders | 38610000.00 |
| % Held by Institutions | 7.23 |
| Shares Short (K) | 4930 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -127810000.000 |
| Book Value (p.s.) | |
| Profit Margin | |
| Operating Margin |  |
| Return on Assets (ttm) | 528.5 |
| Return on Equity (ttm) | -21.9 |
| Qtrly Rev. Growth | 8420000.0 |
| Gross Profit (p.s.) | -30.545 |
| Sales Per Share | -35.273 |
| EBITDA (p.s.) | -83509088.000 |
| Qtrly Earnings Growth | -2.91 |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | -104.71 |
| Stock Valuation | |
|---|---|
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | -0.55 |
| Price to Cash Flow | 2.82 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | 5900000.000 |
